Nasdaq4d
Interesting NRIX Put And Call Options For March 21st
Investors in Nurix Therapeutics Inc (Symbol: NRIX) saw new options begin trading this week, for the March 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Stephens Reiterates “Overweight” Rating for Nurix Therapeutics (NASDAQ:NRIX)
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report)‘s stock had its “overweight” rating restated by Stephens in a report issued on Tuesday,Benzinga reports. They currently have a $31.00 target price on ...
Nurix Therapeutics: Strategic Pipeline Developments and Market Expansion Justify Buy Rating
In a report released today, Jeet Mukherjee from BTIG maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report), with a price ...
Nurix Therapeutics appoints John Northcott as CCO
Nurix Therapeutics (NRIX) announced the appointment of John Northcott as chief commercial officer. From 2022 through 2024, Mr. Northcott served ...
Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer
Mr. Northcott brings over 20 years of biopharmaceutical experience building commercial organizations and successfully commercializing novel products, including BTK inhibitor ibrutinibSAN FRANCISCO, ...
Yahoo Finance4d
Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer
SAN FRANCISCO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat ...
Nasdaq4d
Nurix Therapeutics Appoints John Northcott as Chief Commercial Officer
Nurix Therapeutics, Inc. has appointed John Northcott as its new chief commercial officer, bringing over 20 years of experience in biotechnology commercialization. His background includes ...
Stockhouse4d
Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer
NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced the appointment of John ...
Nurix Therapeutics, Inc.: Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer
Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients ...
Investing4d
Nurix Therapeutics appoints new chief commercial officer
SAN FRANCISCO - Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in targeted protein modulation drugs, announced today the appointment of John Northcott as its new ...
Investing4d
Nurix Therapeutics appoints new chief commercial officer
SAN FRANCISCO - Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in targeted protein modulation drugs, announced today the appointment of John Northcott as its new ...